The companion diagnostics market is on track to reach $6.8 billion by 2025 (from $3.7 billion in 2020), according to…
Super UserJuly 6, 2021
Howard Carolan, Co-Founder and CEO of CoapTech, Inc., and Neil Davis, Program Director of the Biomedical Entrepreneurship Graduate Certificate program…
Super UserJuly 6, 2021
Thanks to unprecedented development speed and mostly strong safety and efficacy data, vaccines have dominated the response to COVID-19. But…
Super UserJuly 1, 2021
This document has been redacted by Sam Collaudin, Kinexum Business Strategy Consultant, independently from any pharmaceutical and biotech companies It…
Super UserJuly 1, 2021
This week, a pair of Frederick companies raised millions in new investment, offering evidence of the Maryland city’s growing role…
Super UserJune 30, 2021
Johns Hopkins University's board of trustees has voted unanimously to add a new five-year term to the presidential tenure of…
Super UserJune 30, 2021
The firm helps gene therapy and vaccine companies develop and manufacture products for rare diseases. Image: Vigene Biosciences, led by…
Super UserJune 30, 2021
GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today…
Super UserJune 30, 2021
Go pakh your cahr, Boston. Grab some granola, California. It’s D.C.’s moment in life sciences. For years, the Washington metropolitan…
Super UserJune 29, 2021